Bio-Gate and Avicanna complete phase of development on CBD and Micro Silver BG™ based skin car
By: INS Trade Media Service
Nuremberg/Bremen, June 29th 2021 – Bio-Gate AG (ISIN DE000BGAG981)
As part of the collaboration, Bio-Gate is developing active cosmetic and dermatology products in collaboration with Avicanna that combine MicroSilver BG™ and CBD (hemp derived) to deliver synergistic anti-inflammatory and antimicrobial effects. Following the development and initial success of in vitro studies, the products will be available for human applications shortly. Target indications and cosmetic benefits of the products include acne, eczema andatopic dermatitis. The products will be initially marketed in Europe and North America. The newly developed products comply with current EU regulations under cosmetic designation and will be made available to existing clients of Bio-Gate in Europe and North America who have expressed significant interest.
Avicanna has extensive experience with cannabinoid product development and has commercialized CBD based skin care products across several markets including North and South America where they will lead commercial efforts on the newly developed products as well. Bio-Gate is primarily responsible for sales and commercialization in European markets. The cooperation with Avicanna follows Bio-Gate's strategy of gradually transferring technologies to new business and application areas, thus opening new markets with new product applications.